Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
22 participants
INTERVENTIONAL
2006-02-28
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness and Acceptability of Insertable Devices for Obstetric Fistula Management
NCT05444504
Feasibility of a Novel Technique for Pilonidal Wound Healing
NCT02330159
Novel Post-Surgical Incision Management to Prevent Ostomy Complications
NCT06524401
Non-Powered Negative Pressure Wound Therapy vs Open Technique for Pilonidal Disease
NCT03483480
ENVELOP: Wound Care Following Pilonidal Sinus Surgery
NCT06647290
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fistula Pouching System
3 different sizes of fistula pounching system
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of giving informed consent
* Have to be hospitalized
* Have a fistula with the opening on the skin in the abdominal area
Exclusion Criteria
* Receiving radiation- or chemotherapy during the investigation period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coloplast A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thais Benjamin N. Christensen, M.Sc. (BME)
Role: STUDY_CHAIR
Coloplast A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Francis Hospital and Medical Center
Hartford, Connecticut, United States
Morton Plant Hospital
Clearwarter, Florida, United States
Fairview Southdale Hospital
Edina, Minnesota, United States
University of Minnesota Medical Center Fairview - Riverside
Minneapolis, Minnesota, United States
University of Minnesota Medical Center Fairview
Minneapolis, Minnesota, United States
The Cleveland Clinic Foundation
Cleveland, Ohio, United States
Presbyterian Hospital of Dallas
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DK140OS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.